1k8a › Citations

The structures of four macrolide antibiotics bound to the large ribosomal subunit.

Hansen JL, Ippolito JA, Ban N, Nissen P, Moore PB, Steitz TA
Mol Cell 10 117-28 (2002)
Related entries: 1k9m, 1kd1, 1m1k

Cited: 303 times
EuropePMC logo PMID: 12150912

Abstract

Crystal structures of the Haloarcula marismortui large ribosomal subunit complexed with the 16-membered macrolide antibiotics carbomycin A, spiramycin, and tylosin and a 15-membered macrolide, azithromycin, show that they bind in the polypeptide exit tunnel adjacent to the peptidyl transferase center. Their location suggests that they inhibit protein synthesis by blocking the egress of nascent polypeptides. The saccharide branch attached to C5 of the lactone rings extends toward the peptidyl transferase center, and the isobutyrate extension of the carbomycin A disaccharide overlaps the A-site. Unexpectedly, a reversible covalent bond forms between the ethylaldehyde substituent at the C6 position of the 16-membered macrolides and the N6 of A2103 (A2062, E. coli). Mutations in 23S rRNA that result in clinical resistance render the binding site less complementary to macrolides.

Reviews - 1k8a mentioned but not cited (3)

  1. Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design. Lin J, Zhou D, Steitz TA, Polikanov YS, Gagnon MG. Annu Rev Biochem 87 451-478 (2018)
  2. Look and Outlook on Enzyme-Mediated Macrolide Resistance. Golkar T, Zieliński M, Berghuis AM. Front Microbiol 9 1942 (2018)
  3. ABC-F translation factors: from antibiotic resistance to immune response. Fostier CR, Monlezun L, Ousalem F, Singh S, Hunt JF, Boël G. FEBS Lett 595 675-706 (2021)

Articles - 1k8a mentioned but not cited (5)

  1. Structural signatures of antibiotic binding sites on the ribosome. David-Eden H, Mankin AS, Mandel-Gutfreund Y. Nucleic Acids Res 38 5982-5994 (2010)
  2. Modeling RNA tertiary structure motifs by graph-grammars. St-Onge K, Thibault P, Hamel S, Major F. Nucleic Acids Res 35 1726-1736 (2007)
  3. Crystallographic characterization of the ribosomal binding site and molecular mechanism of action of Hygromycin A. Kaminishi T, Schedlbauer A, Fabbretti A, Brandi L, Ochoa-Lizarralde B, He CG, Milón P, Connell SR, Gualerzi CO, Fucini P. Nucleic Acids Res 43 10015-10025 (2015)
  4. Protein interactions from complexes: a structural perspective. Hakes L, Robertson DL, Oliver SG, Lovell SC. Comp Funct Genomics 49356 (2007)
  5. Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida. Breiner-Goldstein E, Eyal Z, Matzov D, Halfon Y, Cimicata G, Baum M, Rokney A, Ezernitchi AV, Lowell AN, Schmidt JJ, Rozenberg H, Zimmerman E, Bashan A, Valinsky L, Anzai Y, Sherman DH, Yonath A. Nucleic Acids Res 49 9560-9573 (2021)


Reviews citing this publication (80)

  1. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Wilson DN. Nat Rev Microbiol 12 35-48 (2014)
  2. Where will new antibiotics come from? Walsh C. Nat Rev Microbiol 1 65-70 (2003)
  3. The bacterial ribosome as a target for antibiotics. Poehlsgaard J, Douthwaite S. Nat Rev Microbiol 3 870-881 (2005)
  4. New antibiotics from bacterial natural products. Clardy J, Fischbach MA, Walsh CT. Nat Biotechnol 24 1541-1550 (2006)
  5. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Brown-Elliott BA, Nash KA, Wallace RJ. Clin Microbiol Rev 25 545-582 (2012)
  6. Azithromycin: mechanisms of action and their relevance for clinical applications. Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Pharmacol Ther 143 225-245 (2014)
  7. The A-Z of bacterial translation inhibitors. Wilson DN. Crit Rev Biochem Mol Biol 44 393-433 (2009)
  8. Molecular dynamics simulations of large macromolecular complexes. Perilla JR, Goh BC, Cassidy CK, Liu B, Bernardi RC, Rudack T, Yu H, Wu Z, Schulten K. Curr Opin Struct Biol 31 64-74 (2015)
  9. Multi-targeting by monotherapeutic antibacterials. Silver LL. Nat Rev Drug Discov 6 41-55 (2007)
  10. RNA, the first macromolecular catalyst: the ribosome is a ribozyme. Steitz TA, Moore PB. Trends Biochem Sci 28 411-418 (2003)
  11. A comprehensive review of glycosylated bacterial natural products. Elshahawi SI, Shaaban KA, Kharel MK, Thorson JS. Chem Soc Rev 44 7591-7697 (2015)
  12. The evolving role of chemical synthesis in antibacterial drug discovery. Wright PM, Seiple IB, Myers AG. Angew Chem Int Ed Engl 53 8840-8869 (2014)
  13. Antibiotics targeting ribosomes: resistance, selectivity, synergism and cellular regulation. Yonath A. Annu Rev Biochem 74 649-679 (2005)
  14. Targeting Antibiotic Resistance. Chellat MF, Raguž L, Riedl R. Angew Chem Int Ed Engl 55 6600-6626 (2016)
  15. Structure and Function of the Mitochondrial Ribosome. Greber BJ, Ban N. Annu Rev Biochem 85 103-132 (2016)
  16. Revolutions in RNA secondary structure prediction. Mathews DH. J Mol Biol 359 526-532 (2006)
  17. The macrolide antibiotic renaissance. Dinos GP. Br J Pharmacol 174 2967-2983 (2017)
  18. Programmed drug-dependent ribosome stalling. Ramu H, Mankin A, Vazquez-Laslop N. Mol Microbiol 71 811-824 (2009)
  19. RNA as a drug target: the case of aminoglycosides. Vicens Q, Westhof E. Chembiochem 4 1018-1023 (2003)
  20. Drugs targeting the ribosome. Hermann T. Curr Opin Struct Biol 15 355-366 (2005)
  21. The involvement of RNA in ribosome function. Moore PB, Steitz TA. Nature 418 229-235 (2002)
  22. Antibiotics and the ribosome. Tenson T, Mankin A. Mol Microbiol 59 1664-1677 (2006)
  23. How Macrolide Antibiotics Work. Vázquez-Laslop N, Mankin AS. Trends Biochem Sci 43 668-684 (2018)
  24. The ribosomal peptidyl transferase center: structure, function, evolution, inhibition. Polacek N, Mankin AS. Crit Rev Biochem Mol Biol 40 285-311 (2005)
  25. The structural basis of large ribosomal subunit function. Moore PB, Steitz TA. Annu Rev Biochem 72 813-850 (2003)
  26. Glycosyltransferases: mechanisms and applications in natural product development. Liang DM, Liu JH, Wu H, Wang BB, Zhu HJ, Qiao JJ. Chem Soc Rev 44 8350-8374 (2015)
  27. Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-Tu. Agirrezabala X, Frank J. Q Rev Biophys 42 159-200 (2009)
  28. Antibiotics that target protein synthesis. McCoy LS, Xie Y, Tor Y. Wiley Interdiscip Rev RNA 2 209-232 (2011)
  29. The social life of ribosomal proteins. Brodersen DE, Nissen P. FEBS J 272 2098-2108 (2005)
  30. Species-specific antibiotic-ribosome interactions: implications for drug development. Wilson DN, Harms JM, Nierhaus KH, Schlünzen F, Fucini P. Biol Chem 386 1239-1252 (2005)
  31. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Kannan K, Mankin AS. Ann N Y Acad Sci 1241 33-47 (2011)
  32. Macrolide myths. Mankin AS. Curr Opin Microbiol 11 414-421 (2008)
  33. Avoidance of suicide in antibiotic-producing microbes. Cundliffe E, Demain AL. J Ind Microbiol Biotechnol 37 643-672 (2010)
  34. Improving on nature: antibiotics that target the ribosome. Sutcliffe JA. Curr Opin Microbiol 8 534-542 (2005)
  35. Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin. Gomes C, Martínez-Puchol S, Palma N, Horna G, Ruiz-Roldán L, Pons MJ, Ruiz J. Crit Rev Microbiol 43 1-30 (2017)
  36. From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials. Jelić D, Antolović R. Antibiotics (Basel) 5 E29 (2016)
  37. Chemical and functional diversity of small molecule ligands for RNA. Hermann T. Biopolymers 70 4-18 (2003)
  38. Structure-based drug design meets the ribosome. Franceschi F, Duffy EM. Biochem Pharmacol 71 1016-1025 (2006)
  39. Recent developments in the identification of novel oxazolidinone antibacterial agents. Renslo AR, Luehr GW, Gordeev MF. Bioorg Med Chem 14 4227-4240 (2006)
  40. 16-membered macrolide antibiotics: a review. Arsic B, Barber J, Čikoš A, Mladenovic M, Stankovic N, Novak P. Int J Antimicrob Agents 51 283-298 (2018)
  41. Molecular recognition of RNA: challenges for modelling interactions and plasticity. Fulle S, Gohlke H. J Mol Recognit 23 220-231 (2010)
  42. Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. Int J Mol Sci 20 E5868 (2019)
  43. On the specificity of antibiotics targeting the large ribosomal subunit. Wilson DN. Ann N Y Acad Sci 1241 1-16 (2011)
  44. Ribosomal antibiotics: structural basis for resistance, synergism and selectivity. Auerbach T, Bashan A, Yonath A. Trends Biotechnol 22 570-576 (2004)
  45. Nucleic acid crystallography: current progress. Egli M. Curr Opin Chem Biol 8 580-591 (2004)
  46. Prescribing azithromycin. McMullan BJ, Mostaghim M. Aust Prescr 38 87-89 (2015)
  47. Ribosomal crystallography: initiation, peptide bond formation, and amino acid polymerization are hampered by antibiotics. Yonath A, Bashan A. Annu Rev Microbiol 58 233-251 (2004)
  48. Ribosomal crystallography: peptide bond formation and its inhibition. Bashan A, Zarivach R, Schluenzen F, Agmon I, Harms J, Auerbach T, Baram D, Berisio R, Bartels H, Hansen HA, Fucini P, Wilson D, Peretz M, Kessler M, Yonath A. Biopolymers 70 19-41 (2003)
  49. Mechanisms and structures of vitamin B(6)-dependent enzymes involved in deoxy sugar biosynthesis. Romo AJ, Liu HW. Biochim Biophys Acta 1814 1534-1547 (2011)
  50. On the structural basis of peptide-bond formation and antibiotic resistance from atomic structures of the large ribosomal subunit. Steitz TA. FEBS Lett 579 955-958 (2005)
  51. Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria. Ogawara H. Molecules 24 E3430 (2019)
  52. Actinomycete-Derived Polyketides as a Source of Antibiotics and Lead Structures for the Development of New Antimicrobial Drugs. Robertsen HL, Musiol-Kroll EM. Antibiotics (Basel) 8 E157 (2019)
  53. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae. Zhanel GG, Hisanaga T, Nichol K, Wierzbowski A, Hoban DJ. Expert Opin Emerg Drugs 8 297-321 (2003)
  54. Ribosomal tolerance and peptide bond formation. Yonath A. Biol Chem 384 1411-1419 (2003)
  55. Trans-translation and protein synthesis inhibitors. Vioque A, de la Cruz J. FEMS Microbiol Lett 218 9-14 (2003)
  56. Constraint counting on RNA structures: linking flexibility and function. Fulle S, Gohlke H. Methods 49 181-188 (2009)
  57. Elements of ribosomal drug resistance and specificity. Blaha GM, Polikanov YS, Steitz TA. Curr Opin Struct Biol 22 750-758 (2012)
  58. Translational errors: from yeast to new therapeutic targets. Bidou L, Rousset JP, Namy O. FEMS Yeast Res 10 1070-1082 (2010)
  59. Nitroso Diels-Alder (NDA) reaction as an efficient tool for the functionalization of diene-containing natural products. Carosso S, Miller MJ. Org Biomol Chem 12 7445-7468 (2014)
  60. Tedanolide and the evolution of polyketide inhibitors of eukaryotic protein synthesis. Taylor RE. Nat Prod Rep 25 854-861 (2008)
  61. A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis. Dmitriev SE, Vladimirov DO, Lashkevich KA. Biochemistry (Mosc) 85 1389-1421 (2020)
  62. Intraribosomal regulation of expression and fate of proteins. Nakatogawa H, Ito K. Chembiochem 5 48-51 (2004)
  63. Ribosome's mode of function: myths, facts and recent results. Wekselman I, Davidovich C, Agmon I, Zimmerman E, Rozenberg H, Bashan A, Berisio R, Yonath A. J Pept Sci 15 122-130 (2009)
  64. Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections. Bakowski MA, McNamara CW. Trop Med Infect Dis 4 E108 (2019)
  65. Formation and repair of unavoidable, endogenous interstrand cross-links in cellular DNA. Housh K, Jha JS, Haldar T, Amin SBM, Islam T, Wallace A, Gomina A, Guo X, Nel C, Wyatt JW, Gates KS. DNA Repair (Amst) 98 103029 (2021)
  66. Structural insight into functional aspects of ribosomal RNA targeting. Yonath A. Chembiochem 4 1008-1017 (2003)
  67. The Case against Antibiotics and for Anti-Virulence Therapeutics. Hotinger JA, Morris ST, May AE. Microorganisms 9 2049 (2021)
  68. Advanced Methods for Studying Structure and Interactions of Macrolide Antibiotics. Jednačak T, Mikulandra I, Novak P. Int J Mol Sci 21 E7799 (2020)
  69. An overview of the cytochrome P450 enzymes that catalyze the same-site multistep oxidation reactions in biotechnologically relevant selected actinomycete strains. Iizaka Y, Sherman DH, Anzai Y. Appl Microbiol Biotechnol 105 2647-2661 (2021)
  70. Ribosomal tunnel and translation regulation. Bogdanov AA, Sumbatyan NV, Shishkina AV, Karpenko VV, Korshunova GA. Biochemistry (Mosc) 75 1501-1516 (2010)
  71. Insights into functional modulation of catalytic RNA activity. Vourekas A, Stamatopoulou V, Toumpeki C, Tsitlaidou M, Drainas D. IUBMB Life 60 669-683 (2008)
  72. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases. Eraković Haber V, Bosnar M, Kragol G. Future Med Chem 6 657-674 (2014)
  73. Mechanistic insights into antibiotic action on the ribosome through single-molecule fluorescence imaging. Wang L, Wasserman MR, Feldman MB, Altman RB, Blanchard SC. Ann N Y Acad Sci 1241 E1-16 (2011)
  74. Expansion of the Genetic Code Through the Use of Modified Bacterial Ribosomes. Hecht SM. J Mol Biol 434 167211 (2022)
  75. Multipurpose Drugs Active Against Both Plasmodium spp. and Microorganisms: Potential Application for New Drug Development. Endo T, Takemae H, Sharma I, Furuya T. Front Cell Infect Microbiol 11 797509 (2021)
  76. Use of Azithromycin in Pregnancy: More Doubts than Certainties. Antonucci R, Cuzzolin L, Locci C, Dessole F, Capobianco G. Clin Drug Investig 42 921-935 (2022)
  77. A Review of Antibiotic Efficacy in COVID-19 Control. Hekmat H, Rasooli A, Siami Z, Rutajengwa KA, Vahabi Z, Mirzadeh FA. J Immunol Res 2023 6687437 (2023)
  78. Brief considerations on targeting RNA with small molecules. Vicens Q, Westhof E. Fac Rev 11 39 (2022)
  79. Ribosome-targeting antibiotics and resistance via ribosomal RNA methylation. Jeremia L, Deprez BE, Dey D, Conn GL, Wuest WM. RSC Med Chem 14 624-643 (2023)
  80. The 2009 Nobel Prize in Chemistry: Thomas A. Steitz and the structure of the ribosome. Zhao P. Yale J Biol Med 84 125-129 (2011)

Articles citing this publication (215)

  1. Crystal structure of a 70S ribosome-tRNA complex reveals functional interactions and rearrangements. Korostelev A, Trakhanov S, Laurberg M, Noller HF. Cell 126 1065-1077 (2006)
  2. The roles of ribosomal proteins in the structure assembly, and evolution of the large ribosomal subunit. Klein DJ, Moore PB, Steitz TA. J Mol Biol 340 141-177 (2004)
  3. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Tu D, Blaha G, Moore PB, Steitz TA. Cell 121 257-270 (2005)
  4. Nascent membrane and secretory proteins differ in FRET-detected folding far inside the ribosome and in their exposure to ribosomal proteins. Woolhead CA, McCormick PJ, Johnson AE. Cell 116 725-736 (2004)
  5. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Dunkle JA, Xiong L, Mankin AS, Cate JH. Proc Natl Acad Sci U S A 107 17152-17157 (2010)
  6. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. Hansen JL, Moore PB, Steitz TA. J Mol Biol 330 1061-1075 (2003)
  7. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. Tenson T, Lovmar M, Ehrenberg M. J Mol Biol 330 1005-1014 (2003)
  8. Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. Harms JM, Wilson DN, Schluenzen F, Connell SR, Stachelhaus T, Zaborowska Z, Spahn CM, Fucini P. Mol Cell 30 26-38 (2008)
  9. Molecular mechanism of drug-dependent ribosome stalling. Vazquez-Laslop N, Thum C, Mankin AS. Mol Cell 30 190-202 (2008)
  10. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Bulkley D, Innis CA, Blaha G, Steitz TA. Proc Natl Acad Sci U S A 107 17158-17163 (2010)
  11. Structural basis for the antibiotic activity of ketolides and azalides. Schlünzen F, Harms JM, Franceschi F, Hansen HA, Bartels H, Zarivach R, Yonath A. Structure 11 329-338 (2003)
  12. Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin. Schlünzen F, Pyetan E, Fucini P, Yonath A, Harms JM. Mol Microbiol 54 1287-1294 (2004)
  13. Structural insight into the role of the ribosomal tunnel in cellular regulation. Berisio R, Schluenzen F, Harms J, Bashan A, Auerbach T, Baram D, Yonath A. Nat Struct Biol 10 366-370 (2003)
  14. U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. Gürel G, Blaha G, Moore PB, Steitz TA. J Mol Biol 389 146-156 (2009)
  15. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. Sidhu AB, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA. J Biol Chem 282 2494-2504 (2007)
  16. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Novac O, Guenier AS, Pelletier J. Nucleic Acids Res 32 902-915 (2004)
  17. Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. Vicens Q, Westhof E. J Mol Biol 326 1175-1188 (2003)
  18. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin. Harms JM, Schlünzen F, Fucini P, Bartels H, Yonath A. BMC Biol 2 4 (2004)
  19. The methyltransferase YfgB/RlmN is responsible for modification of adenosine 2503 in 23S rRNA. Toh SM, Xiong L, Bae T, Mankin AS. RNA 14 98-106 (2008)
  20. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges. Yu AM, Choi YH, Tu MJ. Pharmacol Rev 72 862-898 (2020)
  21. The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae. Sherman DH, Li S, Yermalitskaya LV, Kim Y, Smith JA, Waterman MR, Podust LM. J Biol Chem 281 26289-26297 (2006)
  22. Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors. Smith LK, Mankin AS. Antimicrob Agents Chemother 52 1703-1712 (2008)
  23. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Pereyre S, Guyot C, Renaudin H, Charron A, Bébéar C, Bébéar CM. Antimicrob Agents Chemother 48 460-465 (2004)
  24. Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex. Buriánková K, Doucet-Populaire F, Dorson O, Gondran A, Ghnassia JC, Weiser J, Pernodet JL. Antimicrob Agents Chemother 48 143-150 (2004)
  25. Molecular basis for erythromycin-dependent ribosome stalling during translation of the ErmBL leader peptide. Arenz S, Ramu H, Gupta P, Berninghausen O, Beckmann R, Vázquez-Laslop N, Mankin AS, Wilson DN. Nat Commun 5 3501 (2014)
  26. Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome. Tsui WH, Yim G, Wang HH, McClure JE, Surette MG, Davies J. Chem Biol 11 1307-1316 (2004)
  27. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Farrell DJ, Douthwaite S, Morrissey I, Bakker S, Poehlsgaard J, Jakobsen L, Felmingham D. Antimicrob Agents Chemother 47 1777-1783 (2003)
  28. The fragmented mitochondrial ribosomal RNAs of Plasmodium falciparum. Feagin JE, Harrell MI, Lee JC, Coe KJ, Sands BH, Cannone JJ, Tami G, Schnare MN, Gutell RR. PLoS One 7 e38320 (2012)
  29. Size, shape, and flexibility of RNA structures. Hyeon C, Dima RI, Thirumalai D. J Chem Phys 125 194905 (2006)
  30. Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli. Zaman S, Fitzpatrick M, Lindahl L, Zengel J. Mol Microbiol 66 1039-1050 (2007)
  31. Resistance to the macrolide antibiotic tylosin is conferred by single methylations at 23S rRNA nucleotides G748 and A2058 acting in synergy. Liu M, Douthwaite S. Proc Natl Acad Sci U S A 99 14658-14663 (2002)
  32. Accurate structural correlations from maximum likelihood superpositions. Theobald DL, Wuttke DS. PLoS Comput Biol 4 e43 (2008)
  33. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. Pfister P, Jenni S, Poehlsgaard J, Thomas A, Douthwaite S, Ban N, Böttger EC. J Mol Biol 342 1569-1581 (2004)
  34. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Misyurina OY, Chipitsyna EV, Finashutina YP, Lazarev VN, Akopian TA, Savicheva AM, Govorun VM. Antimicrob Agents Chemother 48 1347-1349 (2004)
  35. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition. Starosta AL, Karpenko VV, Shishkina AV, Mikolajka A, Sumbatyan NV, Schluenzen F, Korshunova GA, Bogdanov AA, Wilson DN. Chem Biol 17 504-514 (2010)
  36. Antibiotic susceptibility of mammalian mitochondrial translation. Zhang L, Ging NC, Komoda T, Hanada T, Suzuki T, Watanabe K. FEBS Lett 579 6423-6427 (2005)
  37. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G. Pfister P, Corti N, Hobbie S, Bruell C, Zarivach R, Yonath A, Böttger EC. Proc Natl Acad Sci U S A 102 5180-5185 (2005)
  38. Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site. François B, Szychowski J, Adhikari SS, Pachamuthu K, Swayze EE, Griffey RH, Migawa MT, Westhof E, Hanessian S. Angew Chem Int Ed Engl 43 6735-6738 (2004)
  39. Chalcomycin biosynthesis gene cluster from Streptomyces bikiniensis: novel features of an unusual ketolide produced through expression of the chm polyketide synthase in Streptomyces fradiae. Ward SL, Hu Z, Schirmer A, Reid R, Revill WP, Reeves CD, Petrakovsky OV, Dong SD, Katz L. Antimicrob Agents Chemother 48 4703-4712 (2004)
  40. Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma. Taylor SL, Leong LEX, Mobegi FM, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Rogers GB, Simpson JL. Am J Respir Crit Care Med 200 309-317 (2019)
  41. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics. Diner EJ, Hayes CS. J Mol Biol 386 300-315 (2009)
  42. Binding site of the bridged macrolides in the Escherichia coli ribosome. Xiong L, Korkhin Y, Mankin AS. Antimicrob Agents Chemother 49 281-288 (2005)
  43. Lecture On peptide bond formation, translocation, nascent protein progression and the regulatory properties of ribosomes. Derived on 20 October 2002 at the 28th FEBS Meeting in Istanbul. Agmon I, Auerbach T, Baram D, Bartels H, Bashan A, Berisio R, Fucini P, Hansen HA, Harms J, Kessler M, Peretz M, Schluenzen F, Yonath A, Zarivach R. Eur J Biochem 270 2543-2556 (2003)
  44. Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and antibiotics binding. Fulle S, Gohlke H. J Mol Biol 387 502-517 (2009)
  45. POPSCOMP: an automated interaction analysis of biomolecular complexes. Kleinjung J, Fraternali F. Nucleic Acids Res 33 W342-6 (2005)
  46. Comprehensive genetic selection revealed essential bases in the peptidyl-transferase center. Sato NS, Hirabayashi N, Agmon I, Yonath A, Suzuki T. Proc Natl Acad Sci U S A 103 15386-15391 (2006)
  47. Docking to RNA via root-mean-square-deviation-driven energy minimization with flexible ligands and flexible targets. Guilbert C, James TL. J Chem Inf Model 48 1257-1268 (2008)
  48. L11 domain rearrangement upon binding to RNA and thiostrepton studied by NMR spectroscopy. Jonker HR, Ilin S, Grimm SK, Wöhnert J, Schwalbe H. Nucleic Acids Res 35 441-454 (2007)
  49. Mutational analysis of 16S and 23S rRNA genes of Thermus thermophilus. Gregory ST, Carr JF, Rodriguez-Correa D, Dahlberg AE. J Bacteriol 187 4804-4812 (2005)
  50. Positive control of tylosin biosynthesis: pivotal role of TylR. Stratigopoulos G, Bate N, Cundliffe E. Mol Microbiol 54 1326-1334 (2004)
  51. Substrate specificity of the macrolide-glycosylating enzyme pair DesVII/DesVIII: opportunities, limitations, and mechanistic hypotheses. Borisova SA, Zhang C, Takahashi H, Zhang H, Wong AW, Thorson JS, Liu HW. Angew Chem Int Ed Engl 45 2748-2753 (2006)
  52. Thiostrepton inhibits stable 70S ribosome binding and ribosome-dependent GTPase activation of elongation factor G and elongation factor 4. Walter JD, Hunter M, Cobb M, Traeger G, Spiegel PC. Nucleic Acids Res 40 360-370 (2012)
  53. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. Guschin A, Ryzhikh P, Rumyantseva T, Gomberg M, Unemo M. BMC Infect Dis 15 40 (2015)
  54. Structures of triacetyloleandomycin and mycalamide A bind to the large ribosomal subunit of Haloarcula marismortui. Gürel G, Blaha G, Steitz TA, Moore PB. Antimicrob Agents Chemother 53 5010-5014 (2009)
  55. The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics. Auerbach T, Mermershtain I, Davidovich C, Bashan A, Belousoff M, Wekselman I, Zimmerman E, Xiong L, Klepacki D, Arakawa K, Kinashi H, Mankin AS, Yonath A. Proc Natl Acad Sci U S A 107 1983-1988 (2010)
  56. The structures of antibiotics bound to the E site region of the 50 S ribosomal subunit of Haloarcula marismortui: 13-deoxytedanolide and girodazole. Schroeder SJ, Blaha G, Tirado-Rives J, Steitz TA, Moore PB. J Mol Biol 367 1471-1479 (2007)
  57. Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium. Porter JD, Watson J, Roberts LR, Gill SK, Groves H, Dhariwal J, Almond MH, Wong E, Walton RP, Jones LH, Tregoning J, Kilty I, Johnston SL, Edwards MR. J Antimicrob Chemother 71 2767-2781 (2016)
  58. Production of hygromycin A analogs in Streptomyces hygroscopicus NRRL 2388 through identification and manipulation of the biosynthetic gene cluster. Palaniappan N, Ayers S, Gupta S, Habib el-S, Reynolds KA. Chem Biol 13 753-764 (2006)
  59. Structural basis for 16S ribosomal RNA cleavage by the cytotoxic domain of colicin E3. Ng CL, Lang K, Meenan NA, Sharma A, Kelley AC, Kleanthous C, Ramakrishnan V. Nat Struct Mol Biol 17 1241-1246 (2010)
  60. Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by Mycoplasma bovis. Lerner U, Amram E, Ayling RD, Mikula I, Gerchman I, Harrus S, Teff D, Yogev D, Lysnyansky I. Vet Microbiol 168 365-371 (2014)
  61. Alanine-scanning mutagenesis of the predicted rRNA-binding domain of ErmC' redefines the substrate-binding site and suggests a model for protein-RNA interactions. Maravić G, Bujnicki JM, Feder M, Pongor S, Flögel M. Nucleic Acids Res 31 4941-4949 (2003)
  62. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Waites KB, Crabb DM, Duffy LB. Antimicrob Agents Chemother 47 39-42 (2003)
  63. Molecular architecture of DesI: a key enzyme in the biosynthesis of desosamine. Burgie ES, Holden HM. Biochemistry 46 8999-9006 (2007)
  64. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance. Svetlov MS, Syroegin EA, Aleksandrova EV, Atkinson GC, Gregory ST, Mankin AS, Polikanov YS. Nat Chem Biol 17 412-420 (2021)
  65. The avilamycin resistance determinants AviRa and AviRb methylate 23S rRNA at the guanosine 2535 base and the uridine 2479 ribose. Treede I, Jakobsen L, Kirpekar F, Vester B, Weitnauer G, Bechthold A, Douthwaite S. Mol Microbiol 49 309-318 (2003)
  66. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Foloppe N, Chen IJ, Davis B, Hold A, Morley D, Howes R. Bioorg Med Chem 12 935-947 (2004)
  67. Analysis of transient and catalytic desosamine-binding pockets in cytochrome P-450 PikC from Streptomyces venezuelae. Li S, Ouellet H, Sherman DH, Podust LM. J Biol Chem 284 5723-5730 (2009)
  68. DNA mimicry by a high-affinity anti-NF-kappaB RNA aptamer. Reiter NJ, Maher LJ, Butcher SE. Nucleic Acids Res 36 1227-1236 (2008)
  69. Glycosylation steps during spiramycin biosynthesis in Streptomyces ambofaciens: involvement of three glycosyltransferases and their interplay with two auxiliary proteins. Nguyen HC, Karray F, Lautru S, Gagnat J, Lebrihi A, Huynh TD, Pernodet JL. Antimicrob Agents Chemother 54 2830-2839 (2010)
  70. Isolation of antibiotic resistance mutations in the rRNA by using an in vitro selection system. Cochella L, Green R. Proc Natl Acad Sci U S A 101 3786-3791 (2004)
  71. Production of hybrid 16-membered macrolides by expressing combinations of polyketide synthase genes in engineered Streptomyces fradiae hosts. Reeves CD, Ward SL, Revill WP, Suzuki H, Marcus M, Petrakovsky OV, Marquez S, Fu H, Dong SD, Katz L. Chem Biol 11 1465-1472 (2004)
  72. Microenvironment analysis and identification of magnesium binding sites in RNA. Banatao DR, Altman RB, Klein TE. Nucleic Acids Res 31 4450-4460 (2003)
  73. Role of 16S rRNA Helix 44 in Ribosomal Resistance to Hygromycin B. Pfister P, Risch M, Brodersen DE, Böttger EC. Antimicrob Agents Chemother 47 1496-1502 (2003)
  74. Crystal structure of RlmAI: implications for understanding the 23S rRNA G745/G748-methylation at the macrolide antibiotic-binding site. Das K, Acton T, Chiang Y, Shih L, Arnold E, Montelione GT. Proc Natl Acad Sci U S A 101 4041-4046 (2004)
  75. The role of the universally conserved A2450-C2063 base pair in the ribosomal peptidyl transferase center. Chirkova A, Erlacher MD, Clementi N, Zywicki M, Aigner M, Polacek N. Nucleic Acids Res 38 4844-4855 (2010)
  76. A crevice adjoining the ribosome tunnel: hints for cotranslational folding. Amit M, Berisio R, Baram D, Harms J, Bashan A, Yonath A. FEBS Lett 579 3207-3213 (2005)
  77. Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. Lin C, Li S, Sun H, Zhao H, Feng Y, Cao L, Yuan Y, Zhang T. J Clin Microbiol 48 4567-4572 (2010)
  78. A conserved chloramphenicol binding site at the entrance to the ribosomal peptide exit tunnel. Long KS, Porse BT. Nucleic Acids Res 31 7208-7215 (2003)
  79. Characterization of a 30S ribosomal subunit assembly intermediate found in Escherichia coli cells growing with neomycin or paromomycin. Foster C, Champney WS. Arch Microbiol 189 441-449 (2008)
  80. Fluorescence polarization method to characterize macrolide-ribosome interactions. Yan K, Hunt E, Berge J, May E, Copeland RA, Gontarek RR. Antimicrob Agents Chemother 49 3367-3372 (2005)
  81. Peptide-mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel. Vimberg V, Xiong L, Bailey M, Tenson T, Mankin A. Mol Microbiol 54 376-385 (2004)
  82. S-adenosyl-L-methionine induces compaction of nascent peptide chain inside the ribosomal exit tunnel upon translation arrest in the Arabidopsis CGS1 gene. Onoue N, Yamashita Y, Nagao N, Goto DB, Onouchi H, Naito S. J Biol Chem 286 14903-14912 (2011)
  83. Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain. Koch M, Willi J, Pradère U, Hall J, Polacek N. Nucleic Acids Res 45 6717-6728 (2017)
  84. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. Dinos GP, Connell SR, Nierhaus KH, Kalpaxis DL. Mol Pharmacol 63 617-623 (2003)
  85. Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis. Thompson J, Pratt CA, Dahlberg AE. Antimicrob Agents Chemother 48 4889-4891 (2004)
  86. Gene replacement in Haloarcula marismortui: construction of a strain with two of its three chromosomal rRNA operons deleted. Tu D, Blaha G, Moore PB, Steitz TA. Extremophiles 9 427-435 (2005)
  87. Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes. Lu C, Liao G, Zhang J, Tan H. Microb Cell Fact 14 173 (2015)
  88. Structural analysis of QdtB, an aminotransferase required for the biosynthesis of dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose. Thoden JB, Schäffer C, Messner P, Holden HM. Biochemistry 48 1553-1561 (2009)
  89. The extended loops of ribosomal proteins uL4 and uL22 of Escherichia coli contribute to ribosome assembly and protein translation. Lawrence MG, Shamsuzzaman M, Kondopaka M, Pascual C, Zengel JM, Lindahl L. Nucleic Acids Res 44 5798-5810 (2016)
  90. The tylosin-resistance methyltransferase RlmA(II) (TlrB) modifies the N-1 position of 23S rRNA nucleotide G748. Douthwaite S, Crain PF, Liu M, Poehlsgaard J. J Mol Biol 337 1073-1077 (2004)
  91. 23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22. Berisio R, Corti N, Pfister P, Yonath A, Böttger EC. Antimicrob Agents Chemother 50 3816-3823 (2006)
  92. Characterization of In Vivo acquired resistance of Mycoplasma hyopneumoniae to macrolides and lincosamides. Stakenborg T, Vicca J, Butaye P, Maes D, Minion FC, Peeters J, De Kruif A, Haesebrouck F. Microb Drug Resist 11 290-294 (2005)
  93. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. Novotny GW, Jakobsen L, Andersen NM, Poehlsgaard J, Douthwaite S. Antimicrob Agents Chemother 48 3677-3683 (2004)
  94. Mutation from guanine to adenine in 25S rRNA at the position equivalent to E. coli A2058 does not confer erythromycin sensitivity in Sacchromyces cerevisae. Bommakanti AS, Lindahl L, Zengel JM. RNA 14 460-464 (2008)
  95. Time-resolved binding of azithromycin to Escherichia coli ribosomes. Petropoulos AD, Kouvela EC, Starosta AL, Wilson DN, Dinos GP, Kalpaxis DL. J Mol Biol 385 1179-1192 (2009)
  96. Vancomycin analogues containing monosaccharides exhibit improved antibiotic activity: a combined one-pot enzymatic glycosylation and chemical diversification strategy. Thayer DA, Wong CH. Chem Asian J 1 445-452 (2006)
  97. Biosynthetic origin of hygromycin A. Habib el-SE, Scarsdale JN, Reynolds KA. Antimicrob Agents Chemother 47 2065-2071 (2003)
  98. Chemistry and biology of macrolide antiparasitic agents. Lee Y, Choi JY, Fu H, Harvey C, Ravindran S, Roush WR, Boothroyd JC, Khosla C. J Med Chem 54 2792-2804 (2011)
  99. Free and bound state structures of 6-O-methyl homoerythromycins and epitope mapping of their interactions with ribosomes. Novak P, Barber J, Cikos A, Arsic B, Plavec J, Lazarevski G, Tepes P, Kosutić-Hulita N. Bioorg Med Chem 17 5857-5867 (2009)
  100. Polyamines affect diversely the antibiotic potency: insight gained from kinetic studies of the blasticidin S AND spiramycin interactions with functional ribosomes. Petropoulos AD, Xaplanteri MA, Dinos GP, Wilson DN, Kalpaxis DL. J Biol Chem 279 26518-26525 (2004)
  101. Accumulation and turnover of 23S ribosomal RNA in azithromycin-inhibited ribonuclease mutant strains of Escherichia coli. Silvers JA, Champney WS. Arch Microbiol 184 66-77 (2005)
  102. High-content screening for compounds that affect mtDNA-encoded protein levels in eukaryotic cells. Nadanaciva S, Dillman K, Gebhard DF, Shrikhande A, Will Y. J Biomol Screen 15 937-948 (2010)
  103. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics. Karahalios P, Kalpaxis DL, Fu H, Katz L, Wilson DN, Dinos GP. Mol Pharmacol 70 1271-1280 (2006)
  104. Discovery and Analysis of Natural-Product Compounds Inhibiting Protein Synthesis in Pseudomonas aeruginosa. Hu Y, Keniry M, Palmer SO, Bullard JM. Antimicrob Agents Chemother 60 4820-4829 (2016)
  105. Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity. Kouvela EC, Kalpaxis DL, Wilson DN, Dinos GP. Antimicrob Agents Chemother 53 1411-1419 (2009)
  106. Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae. Chancey ST, Zhou X, Zähner D, Stephens DS. Antimicrob Agents Chemother 55 3413-3422 (2011)
  107. Structural Basis for Kinase-Mediated Macrolide Antibiotic Resistance. Fong DH, Burk DL, Blanchet J, Yan AY, Berghuis AM. Structure 25 750-761.e5 (2017)
  108. Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics. Liang CH, Yao S, Chiu YH, Leung PY, Robert N, Seddon J, Sears P, Hwang CK, Ichikawa Y, Romero A. Bioorg Med Chem Lett 15 1307-1310 (2005)
  109. The ribosome as a drug target. Böttger EC. Trends Biotechnol 24 145-147 (2006)
  110. Cryo-EM Determination of Eravacycline-Bound Structures of the Ribosome and the Multidrug Efflux Pump AdeJ of Acinetobacter baumannii. Zhang Z, Morgan CE, Bonomo RA, Yu EW. mBio 12 e0103121 (2021)
  111. Functional characterization and phylogenetic analysis of acquired and intrinsic macrolide phosphotransferases in the Bacillus cereus group. Wang C, Sui Z, Leclercq SO, Zhang G, Zhao M, Chen W, Feng J. Environ Microbiol 17 1560-1573 (2015)
  112. Impact of ribosomal modification on the binding of the antibiotic telithromycin using a combined grand canonical monte carlo/molecular dynamics simulation approach. Small MC, Lopes P, Andrade RB, Mackerell AD. PLoS Comput Biol 9 e1003113 (2013)
  113. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA. Wu CM, Wu H, Ning Y, Wang J, Du X, Shen J. FEMS Microbiol Lett 247 199-205 (2005)
  114. Inhibition of protein synthesis on the ribosome by tildipirosin compared with other veterinary macrolides. Andersen NM, Poehlsgaard J, Warrass R, Douthwaite S. Antimicrob Agents Chemother 56 6033-6036 (2012)
  115. Molecular markers for rapidly identifying candidate genes in Chlamydomonas reinhardtii. Ery1 and ery2 encode chloroplast ribosomal proteins. Bowers AK, Keller JA, Dutcher SK. Genetics 164 1345-1353 (2003)
  116. Assessment of Draxxin® (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi. Silva MG, Villarino NF, Knowles DP, Suarez CE. Int J Parasitol Drugs Drug Resist 8 265-270 (2018)
  117. Context-specific action of macrolide antibiotics on the eukaryotic ribosome. Svetlov MS, Koller TO, Meydan S, Shankar V, Klepacki D, Polacek N, Guydosh NR, Vázquez-Laslop N, Wilson DN, Mankin AS. Nat Commun 12 2803 (2021)
  118. Decreased Susceptibility to Macrolide-Lincosamide in Mycoplasma synoviae Is Associated with Mutations in 23S Ribosomal RNA. Lysnyansky I, Gerchman I, Flaminio B, Catania S. Microb Drug Resist 21 581-589 (2015)
  119. Novel base triples in RNA structures revealed by graph theoretical searching methods. Firdaus-Raih M, Harrison AM, Willett P, Artymiuk PJ. BMC Bioinformatics 12 Suppl 13 S2 (2011)
  120. Searching for a wrench to throw into the splicing machine. Jurica MS. Nat Chem Biol 4 3-6 (2008)
  121. The Cyanobacterial Ribosomal-Associated Protein LrtA Is Involved in Post-Stress Survival in Synechocystis sp. PCC 6803. Galmozzi CV, Florencio FJ, Muro-Pastor MI. PLoS One 11 e0159346 (2016)
  122. The origin of a derived superkingdom: how a gram-positive bacterium crossed the desert to become an archaeon. Valas RE, Bourne PE. Biol Direct 6 16 (2011)
  123. Design, synthesis, and biological evaluation of BODIPY-erythromycin probes for bacterial ribosomes. Li J, Kim IH, Roche ED, Beeman D, Lynch AS, Ding CZ, Ma Z. Bioorg Med Chem Lett 16 794-797 (2006)
  124. Discovery and analysis of 4H-pyridopyrimidines, a class of selective bacterial protein synthesis inhibitors. Ribble W, Hill WE, Ochsner UA, Jarvis TC, Guiles JW, Janjic N, Bullard JM. Antimicrob Agents Chemother 54 4648-4657 (2010)
  125. Molecular mechanisms by which rRNA mutations confer resistance to clindamycin. Poehlsgaard J, Pfister P, Böttger EC, Douthwaite S. Antimicrob Agents Chemother 49 1553-1555 (2005)
  126. On the use of the antibiotic chloramphenicol to target polypeptide chain mimics to the ribosomal exit tunnel. Mamos P, Krokidis MG, Papadas A, Karahalios P, Starosta AL, Wilson DN, Kalpaxis DL, Dinos GP. Biochimie 95 1765-1772 (2013)
  127. Recognition elements in rRNA for the tylosin resistance methyltransferase RlmA(II). Lebars I, Husson C, Yoshizawa S, Douthwaite S, Fourmy D. J Mol Biol 372 525-534 (2007)
  128. Comparative proteomic analysis reveals drug resistance of Staphylococcus xylosus ATCC700404 under tylosin stress. Liu X, Wang J, Chen M, Che R, Ding W, Yu F, Zhou Y, Cui W, Xiaoxu X, God'spower BO, Li Y. BMC Vet Res 15 224 (2019)
  129. Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity. Zhang B, Kopper TJ, Liu X, Cui Z, Van Lanen SG, Gensel JC. CNS Neurosci Ther 25 591-600 (2019)
  130. Methylation of 23S rRNA nucleotide G745 is a secondary function of the RlmAI methyltransferase. Liu M, Novotny GW, Douthwaite S. RNA 10 1713-1720 (2004)
  131. Antimicrobial Resistance Genes in Bacteria Isolated From Japanese Honey, and Their Potential for Conferring Macrolide and Lincosamide Resistance in the American Foulbrood Pathogen Paenibacillus larvae. Okamoto M, Kumagai M, Kanamori H, Takamatsu D. Front Microbiol 12 667096 (2021)
  132. Conformational analysis of oleandomycin and its 8-methylene-9-oxime derivative by NMR and molecular modelling. Novak P, Tomisić ZB, Tepes P, Lazarevski G, Plavec J, Turkalj G. Org Biomol Chem 3 39-47 (2005)
  133. Effect of the macrolide antibacterial drug, tylosin, on TNBS-induced colitis in the rat. Menozzi A, Pozzoli C, Poli E, Lazzaretti M, Cantoni A, Grandi D, Giovannini E, Coruzzi G. Pharmacology 74 135-142 (2005)
  134. Lateral-flow immunoassay for detecting drug-induced inhibition of mitochondrial DNA replication and mtDNA-encoded protein synthesis. Nadanaciva S, Willis JH, Barker ML, Gharaibeh D, Capaldi RA, Marusich MF, Will Y. J Immunol Methods 343 1-12 (2009)
  135. Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible. Takaya A, Sato Y, Shoji T, Yamamoto T. Antimicrob Agents Chemother 57 3789-3796 (2013)
  136. Parametrization of macrolide antibiotics using the force field toolkit. Pavlova A, Gumbart JC. J Comput Chem 36 2052-2063 (2015)
  137. Plant defensin antibacterial mode of action against Pseudomonas species. Sathoff AE, Lewenza S, Samac DA. BMC Microbiol 20 173 (2020)
  138. Synthesis and antibacterial activity of 4''-O-heteroarylcarbamoyl derivatives of macrolide. Xu P, Liu L, Jin ZP, Wang GQ, Liu J, Li Y, Lei PS. Bioorg Med Chem Lett 18 5507-5511 (2008)
  139. Synthesis and antibacterial activity of a series of novel 9-O-acetyl- 4'-substituted 16-membered macrolides derived from josamycin. Zhao Z, Jin L, Xu Y, Zhu D, Liu Y, Liu C, Lei P. Bioorg Med Chem Lett 24 480-484 (2014)
  140. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea. Kim HB, Lee B, Jang HC, Kim SH, Kang CI, Choi YJ, Park SW, Kim BS, Kim EC, Oh MD, Choe KW. Microb Drug Resist 10 248-254 (2004)
  141. Chalcomycins from Marine-Derived Streptomyces sp. and Their Antimicrobial Activities. Jiang S, Zhang L, Pei X, Deng F, Hu D, Chen G, Wang C, Hong K, Yao X, Gao AH. Mar Drugs 15 E153 (2017)
  142. Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides. Chen X, Xu P, Xu Y, Liu L, Liu Y, Zhu D, Lei P. Bioorg Med Chem Lett 22 7402-7405 (2012)
  143. Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method. Felde O, Kreizinger Z, Sulyok KM, Hrivnák V, Kiss K, Jerzsele Á, Biksi I, Gyuranecz M. PLoS One 13 e0209030 (2018)
  144. Molecular Dynamics Investigation of a Mechanism of Allosteric Signal Transmission in Ribosomes. Makarov GI, Golovin AV, Sumbatyan NV, Bogdanov AA. Biochemistry (Mosc) 80 1047-1056 (2015)
  145. Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis. Akshay S, Bertea M, Hobbie SN, Oettinghaus B, Shcherbakov D, Böttger EC, Akbergenov R. Antimicrob Agents Chemother 55 4096-4102 (2011)
  146. RlmCD-mediated U747 methylation promotes efficient G748 methylation by methyltransferase RlmAII in 23S rRNA in Streptococcus pneumoniae; interplay between two rRNA methylations responsible for telithromycin susceptibility. Shoji T, Takaya A, Sato Y, Kimura S, Suzuki T, Yamamoto T. Nucleic Acids Res 43 8964-8972 (2015)
  147. Synthesis and in vitro antibiotic activity of 16-membered 9-O-arylalkyloxime macrolides. Fu H, Marquez S, Gu X, Katz L, Myles DC. Bioorg Med Chem Lett 16 1259-1266 (2006)
  148. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA. Wakiyama Y, Kumura K, Umemura E, Masaki S, Ueda K, Watanabe T, Yamamoto M, Hirai Y, Ajito K. J Antibiot (Tokyo) 69 428-439 (2016)
  149. Synthesis of a chlorogenin glycoside library using an orthogonal protecting group strategy. Wang YH, Yeh HW, Wang HW, Yu CC, Guh JH, Liu DZ, Liang PH. Carbohydr Res 375 118-135 (2013)
  150. A Single Gene Cluster for Chalcomycins and Aldgamycins: Genetic Basis for Bifurcation of Their Biosynthesis. Tang XL, Dai P, Gao H, Wang CX, Chen GD, Hong K, Hu D, Yao XS. Chembiochem 17 1241-1249 (2016)
  151. Cheminformatics Analysis and Modeling with MacrolactoneDB. Zin PPK, Williams GJ, Ekins S. Sci Rep 10 6284 (2020)
  152. Cheminformatics-based enumeration and analysis of large libraries of macrolide scaffolds. Zin PPK, Williams G, Fourches D. J Cheminform 10 53 (2018)
  153. Design, synthesis and ribosome binding of chloramphenicol nucleotide and intercalator conjugates. Johansson D, Jessen CH, Pøhlsgaard J, Jensen KB, Vester B, Pedersen EB, Nielsen P. Bioorg Med Chem Lett 15 2079-2083 (2005)
  154. Designer drugs for discerning bugs. Douthwaite S. Proc Natl Acad Sci U S A 107 17065-17066 (2010)
  155. Preparation and biological evaluation of novel leucomycin analogs derived from nitroso Diels-Alder reactions. Yang B, Zöllner T, Gebhardt P, Möllmann U, Miller MJ. Org Biomol Chem 8 691-697 (2010)
  156. Structure of Dirithromycin Bound to the Bacterial Ribosome Suggests New Ways for Rational Improvement of Macrolides. Khabibullina NF, Tereshchenkov AG, Komarova ES, Syroegin EA, Shiriaev DI, Paleskava A, Kartsev VG, Bogdanov AA, Konevega AL, Dontsova OA, Sergiev PV, Osterman IA, Polikanov YS. Antimicrob Agents Chemother 63 e02266-18 (2019)
  157. Synthesis and biological investigation of new 4''-malonyl tethered derivatives of erythromycin and clarithromycin. Sherman D, Xiong L, Mankin AS, Melman A. Bioorg Med Chem Lett 16 1506-1509 (2006)
  158. A genome-wide analysis of targets of macrolide antibiotics in mammalian cells. Gupta A, Ökesli-Armlovich A, Morgens D, Bassik MC, Khosla C. J Biol Chem 295 2057-2067 (2020)
  159. Comprehensive screening of antimicrobials to control phytoplasma diseases using an in vitro plant-phytoplasma co-culture system. Tanno K, Maejima K, Miyazaki A, Koinuma H, Iwabuchi N, Kitazawa Y, Nijo T, Hashimoto M, Yamaji Y, Namba S. Microbiology (Reading) 164 1048-1058 (2018)
  160. Identification of two regulatory genes involved in carbomycin biosynthesis in Streptomyces thermotolerans. Zhong J, Lu Z, Dai J, He W. Arch Microbiol 199 1023-1033 (2017)
  161. Induction of a stress response in Lactococcus lactis is associated with a resistance to ribosomally active antibiotics. Dorrian JM, Briggs DA, Ridley ML, Layfield R, Kerr ID. FEBS J 278 4015-4024 (2011)
  162. Ribosomes containing mutants of L4 ribosomal protein from Thermus thermophilus display multiple defects in ribosomal functions and sensitivity against erythromycin. Tsagkalia A, Leontiadou F, Xaplanteri MA, Papadopoulos G, Kalpaxis DL, Choli-Papadopoulou T. RNA 11 1633-1639 (2005)
  163. SIME: synthetic insight-based macrolide enumerator to generate the V1B library of 1 billion macrolides. Zin PPK, Williams G, Fourches D. J Cheminform 12 23 (2020)
  164. Lecture Structural insights into the functions of the large ribosomal subunit, a major antibiotic target. Steitz TA. Keio J Med 57 1-14 (2008)
  165. Synthesis of novel 4'-substituted 16-membered ring macrolide antibiotics derived from leucomycins. Wang Z, Jian T, Phan LT, Or YS. Bioorg Med Chem Lett 14 519-521 (2004)
  166. [Peptide derivatives of tylosin-related macrolides]. Korshunova GA, Sumbatian NV, Fedorova NV, Kuznetsova IV, Shishkina AV, Bogdanov AA. Bioorg Khim 33 235-244 (2007)
  167. 16-Membered Macrolide Lactone Derivatives Bearing a Triazole-Functionalized Arm at the Aglycone C13 Position as Antibacterial and Anticancer Agents. Domagalska J, Janas A, Pyta K, Pecyna P, Ruszkowski P, Celewicz L, Gajecka M, Bartl F, Przybylski P. ChemMedChem 11 1886-1891 (2016)
  168. A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides. Peric M, Pešić D, Alihodžić S, Fajdetić A, Herreros E, Gamo FJ, Angulo-Barturen I, Jiménez-Díaz MB, Ferrer-Bazaga S, Martínez MS, Gargallo-Viola D, Mathis A, Kessler A, Banjanac M, Padovan J, Bencetić Mihaljević V, Munic Kos V, Bukvić M, Eraković Haber V, Spaventi R. Br J Pharmacol 178 363-377 (2021)
  169. Letter Conformational study of tylosin A in water and full assignments of 1 H and 13 C spectra of tylosin A in D2 O and tylosin B in CDCl3. Arsic B, Aguilar JA, Bryce RA, Barber J. Magn Reson Chem 55 367-373 (2017)
  170. Desosamine in multicomponent reactions. Achatz S, Dömling A. Bioorg Med Chem Lett 16 6360-6362 (2006)
  171. In vitro susceptibility and a new point mutation associated with tylosin-resistance in Japanese canine intestinal spirochetes. Prapasarakul N, Ochi K, Adachi Y. J Vet Med Sci 65 1275-1280 (2003)
  172. Macrolides: the plug is out. Gamerdinger M, Deuerling E. Cell 151 469-471 (2012)
  173. NMR structure of the peptidyl transferase RNA inhibitor antibiotic amicetin. Shammas C, Donarski JA, Ramesh V. Magn Reson Chem 45 133-141 (2007)
  174. Photolabile anticodon stem-loop analogs of tRNAPhe as probes of ribosomal structure and structural fluctuation at the decoding center. Druzina Z, Cooperman BS. RNA 10 1550-1562 (2004)
  175. Proteomic analysis of tylosin-resistant Mycoplasma gallisepticum reveals enzymatic activities associated with resistance. Xia X, Wu C, Cui Y, Kang M, Li X, Ding S, Shen J. Sci Rep 5 17077 (2015)
  176. Quantitative mapping of mRNA 3' ends in Pseudomonas aeruginosa reveals a pervasive role for premature 3' end formation in response to azithromycin. Konikkat S, Scribner MR, Eutsey R, Hiller NL, Cooper VS, McManus J. PLoS Genet 17 e1009634 (2021)
  177. Structural basis for the inability of chloramphenicol to inhibit peptide bond formation in the presence of A-site glycine. Syroegin EA, Aleksandrova EV, Polikanov YS. Nucleic Acids Res 50 7669-7679 (2022)
  178. Toward the rational design of macrolide antibiotics to combat resistance. Pavlova A, Parks JM, Oyelere AK, Gumbart JC. Chem Biol Drug Des 90 641-652 (2017)
  179. [Amino acid and peptide derivatives of the tylosin family of macrolide antibiotics modified at the aldehyde group]. Sumbatian NV, Kuznetsova IV, Karpenko VV, Fedorova NV, Chertkov VA, Korshunova GA, Bogdanov AA. Bioorg Khim 36 265-276 (2010)
  180. A variation of the translation attenuation model can explain the inducible regulation of the pBC16 tetracycline resistance gene in Bacillus subtilis. Lodato PB, Rogers EJ, Lovett PS. J Bacteriol 188 4749-4758 (2006)
  181. Editorial Back to the future: the ribosome as an antibiotic target. Franceschi F. Future Microbiol 2 571-574 (2007)
  182. Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques. Slay RM, Hewitt JA, Crumrine M. Clin Infect Dis 75 S411-S416 (2022)
  183. Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel. Washington AZ, Tapadar S, George A, Oyelere AK. Bioorg Med Chem 23 5198-5209 (2015)
  184. Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation. Voigt M, Savelsberg C, Jaeger M. J Vis Exp (2018)
  185. Interaction of the tylosin-resistance methyltransferase RlmA II at its rRNA target differs from the orthologue RlmA I. Douthwaite S, Jakobsen L, Yoshizawa S, Fourmy D. J Mol Biol 378 969-975 (2008)
  186. Modeling Interactions of Erythromycin Derivatives with Ribosomes. Shishkina AV, Makarova TM, Tereshchenkov AG, Makarov GI, Korshunova GA, Bogdanov AA. Biochemistry (Mosc) 80 1500-1507 (2015)
  187. NMR characterisation of a highly conserved secondary structural RNA motif of Halobacterium halobium 23S rRNA. King J, Shammas C, Nareen M, Lelli M, Ramesh V. Org Biomol Chem 11 3382-3392 (2013)
  188. Structural Insight into Interaction between C20 Phenylalanyl Derivative of Tylosin and Ribosomal Tunnel. Makarov GI, Sumbatyan NV, Bogdanov AA. Biochemistry (Mosc) 82 925-932 (2017)
  189. Synthesis and activity of new macrolones: conjugates between 6(7)-(2'-aminoethyl)-amino-1-cyclopropyl-3-carboxylic acid (2'-hydroxyethyl) amides and 4″-propenoyl-azithromycin. Kapić S, Fajdetić A, Koštrun S, Cikoš A, Paljetak HČ, Antolović R, Holmes DJ, Alihodžić S. Bioorg Med Chem 19 7270-7280 (2011)
  190. Assembling Pharma Resources to Tackle Diseases of Underserved Populations. Kempf DJ, Marsh KC. ACS Med Chem Lett 11 1094-1100 (2020)
  191. Clarithromycin Exerts an Antibiofilm Effect against Salmonella enterica Serovar Typhimurium rdar Biofilm Formation and Transforms the Physiology towards an Apparent Oxygen-Depleted Energy and Carbon Metabolism. Zafar M, Jahan H, Jahan H, Shafeeq S, Nimtz M, Jänsch L, Römling U, Choudhary MI. Infect Immun 88 e00510-20 (2020)
  192. Classification of ligand molecules in PDB with graph match-based structural superposition. Shionyu-Mitsuyama C, Hijikata A, Tsuji T, Shirai T. J Struct Funct Genomics 17 135-146 (2016)
  193. Cytochrome P450 enzyme RosC catalyzes a multistep oxidation reaction to form the non-active compound 20-carboxyrosamicin. Iizaka Y, Takeda R, Senzaki Y, Fukumoto A, Anzai Y. FEMS Microbiol Lett 364 (2017)
  194. Design, synthesis and biological evaluation of azithromycin glycosyl derivatives as potential antibacterial agents. Zhang L, Chai X, Wang B, Yu S, Hu H, Zou Y, Zhao Q, Meng Q, Wu Q. Bioorg Med Chem Lett 23 5057-5060 (2013)
  195. In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA. Sugiyama H, Yoshida I, Ueki M, Tanabe K, Manaka A, Hiramatsu K. J Antibiot (Tokyo) 70 264-271 (2017)
  196. Rapid Structure Determination of Bioactive 4″-Tetrahydrofurfuryl Macrozone Reaction Mixture Components by LC-SPE/Cryo NMR and MS. Habinovec I, Mikulandra I, Sekula LE, Gašperov J, Kazazić S, Novak P. Molecules 26 6316 (2021)
  197. The slow dissociation rate of K-1602 contributes to the enhanced inhibitory activity of this novel alkyl-aryl-bearing fluoroketolide. Krokidis M, Bougas A, Stavropoulou M, Kalpaxis D, Dinos GP. J Enzyme Inhib Med Chem 31 276-282 (2016)
  198. Antibiotic Azithromycin inhibits brown/beige fat functionality and promotes obesity in human and rodents. Yu J, Chen X, Zhang Y, Cui X, Zhang Z, Guo W, Wang D, Huang S, Chen Y, Hu Y, Zhao C, Qiu J, Li Y, Meng M, Guo M, Shen F, Zhang M, Zhou B, Gu X, Wang J, Wang X, Ma X, Xu L. Theranostics 12 1187-1203 (2022)
  199. Changes in the level of poly(Phe) synthesis in Escherichia coli ribosomes containing mutants of L4 ribosomal protein from Thermus thermophilus can be explained by structural changes in the peptidyltransferase center: a molecular dynamics simulation analysis. Papadopoulos G, Grudinin S, Kalpaxis DL, Choli-Papadopoulou T. Eur Biophys J 35 675-683 (2006)
  200. Dihydrochalcomycin Production and Glycosyltransferase from Streptomyces SP. KCTC 0041BP. Thuy TT, Sohng JK, Pfeifer B. EJIFCC 20 171-175 (2010)
  201. Congress European Symposium of Bio-Organic Chemistry 2003 (ESBOC): the evolution of catalysis. Lindner A, Hollfelder F. Chembiochem 5 241-243 (2004)
  202. Molecular Mechanism of Staphylococcus xylosus Resistance Against Tylosin and Florfenicol. Chen M, Li Y, Li S, Cui W, Zhou Y, Qu Q, Che R, Li L, Yuan S, Liu X. Infect Drug Resist 15 6165-6176 (2022)
  203. Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in non-tuberculous mycobacteria isolates from Kenya. Mwangi Z, Naeku G, Mureithi M, Onyambu F, Bulimo W. F1000Res 11 962 (2022)
  204. Phage-Related Ribosomal Proteases (Prps): Discovery, Bioinformatics, and Structural Analysis. Hotinger JA, Gallagher AH, May AE. Antibiotics (Basel) 11 1109 (2022)
  205. Quality control of protein synthesis in the early elongation stage. Nagao A, Nakanishi Y, Yamaguchi Y, Mishina Y, Karoji M, Toya T, Fujita T, Iwasaki S, Miyauchi K, Sakaguchi Y, Suzuki T. Nat Commun 14 2704 (2023)
  206. Quantum chemical investigation of predominant conformation of the antibiotic azithromycin in water and DMSO solutions: thermodynamic and NMR analysis. Hernandes IS, Da Silva HC, Dos Santos HF, Ávila EP, De Almeida MV, De Almeida WB. R Soc Open Sci 10 230409 (2023)
  207. Refinement of a low-resolution crystal structure to better understand erythromycin interactions on large ribosomal subunit. Wahab HA, Yam WK, Samian MR, Najimudin N. J Biomol Struct Dyn 26 131-146 (2008)
  208. Regulation of the macrolide resistance ABC-F translation factor MsrD. Fostier CR, Ousalem F, Leroy EC, Ngo S, Soufari H, Innis CA, Hashem Y, Boël G. Nat Commun 14 3891 (2023)
  209. Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism. Lomakin IB, Devarkar SC, Patel S, Grada A, Bunick CG. Nucleic Acids Res 51 2915-2930 (2023)
  210. Screening of Novel Antimicrobial Diastereomers of Azithromycin-Thiosemicarbazone Conjugates: A Combined LC-SPE/Cryo NMR, MS/MS and Molecular Modeling Approach. Habinovec I, Mikulandra I, Pranjić P, Kazazić S, Paljetak HČ, Barišić A, Bertoša B, Bukvić M, Novak P. Antibiotics (Basel) 11 1738 (2022)
  211. Structural basis of Cfr-mediated antimicrobial resistance and mechanisms to evade it. Aleksandrova EV, Wu KJY, Tresco BIC, Syroegin EA, Killeavy EE, Balasanyants SM, Svetlov MS, Gregory ST, Atkinson GC, Myers AG, Polikanov YS. Nat Chem Biol (2024)
  212. The dark side of the ribosome life cycle. Ferreira-Cerca S. RNA Biol 19 1045-1049 (2022)
  213. Thermus thermophilus L4 ribosomal protein: purification and sensitivity alteration against erythromycin of E. coli cells harboring a single amino acid mutant of TthL4 within its extended loop. Leontiadou F, Tsagkalia A, Choli-Papadopoulou T. Amino Acids 33 463-468 (2007)
  214. Uncovering Key Metabolic Determinants of the Drug Interactions Between Trimethoprim and Erythromycin in Escherichia coli. Qi Q, Angermayr SA, Bollenbach T. Front Microbiol 12 760017 (2021)
  215. Unprecedented Epimerization of an Azithromycin Analogue: Synthesis, Structure and Biological Activity of 2'-Dehydroxy-5″-Epi-Azithromycin. Kragol G, Steadman VA, Marušić Ištuk Z, Čikoš A, Bosnar M, Jelić D, Ergović G, Trzun M, Bošnjak B, Bokulić A, Padovan J, Glojnarić I, Eraković Haber V. Molecules 27 1034 (2022)


Related citations provided by authors (2)

  1. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA Science 289 905-920 (2000)
  2. The structural basis of ribosome activity in peptide bond synthesis. Nissen P, Hansen J, Ban N, Moore PB, Steitz TA Science 289 920-930 (2000)

Quick links